| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.4 | 0.2 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |